# Pharmacokinetics of Bivalirudin for Pediatric Anticoagulation

> **NCT03532399** · — · RECRUITING · sponsor: **Boston Children's Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Drug Effect

## Interventions

- **DRUG:** Bivalirudin

## Key facts

- **NCT ID:** NCT03532399
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-07-12
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03532399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03532399, "Pharmacokinetics of Bivalirudin for Pediatric Anticoagulation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03532399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*